The wound care company Odinwell receives SEK 0.65 million from warrants. The company announces that the exercise period for warrants of series TO 2 has ended. In total, just under 4 million warrants were exercised, corresponding to an exercise rate of about 76.6 percent.Through the warrant exercise, shares were subscribed for at about SEK 0.65 million before customary costs attributable to the exercise process. The subscription price amounted to SEK 0.164 per share.The company says that the capital injection strengthens the financial position and is intended to support the continued work to commercialize the company’s solutions.